{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the causal molecule for autosomal-dominant familial Parkinson’s disease, although its true function, including its physiological substrates, remains unknown. Parkinson’s disease (PD) is the second most common neurodegenerative disorder caused by loss of nigrostriatal dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as neurodegeneration caused by loss of dopaminergic neurons, which is relevant to the functional assay being described for the LRRK2 variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro kinase assay with recombinant proteins and knockdown experiment using intact cells were used to demonstrate that LRRK2 directly phosphorylates Akt1, a central molecule involved in signal transduction for cell survival and prevention of apoptosis.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used, in vitro kinase assays and knockdown experiments, effectively models or reflects the disease pathogenesis/mechanism defined in Step 1, as they directly assess the effect of LRRK2 on its substrate Akt1, which is central to cell survival and apoptosis, relevant to neurodegeneration in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper includes both wild-type and mutant forms of LRRK2 in the assays, providing variant controls. It also mentions the use of recombinant proteins and intact cells, which are standard techniques in the field."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The variant R1441C in LRRK2 showed significantly weaker kinase activity of Akt1 (Ser473)-phosphorylation than the wild-type LRRK2, suggesting a loss of function mechanism that could contribute to neurodegeneration in Parkinson's disease. The functional evidence is very strong due to the clear disease mechanism, the applicability of the assays, and the direct comparison with wild-type LRRK2."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the causal molecule for autosomal-dominant familial Parkinson’s disease, although its true function, including its physiological substrates, remains unknown. Parkinson’s disease (PD) is the second most common neurodegenerative disorder caused by loss of nigrostriatal dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as neurodegeneration caused by loss of dopaminergic neurons, which is relevant to the functional assay being described for the LRRK2 variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro kinase assay with recombinant proteins and knockdown experiment using intact cells were used to demonstrate that LRRK2 directly phosphorylates Akt1, a central molecule involved in signal transduction for cell survival and prevention of apoptosis.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used, in vitro kinase assays and knockdown experiments, effectively models or reflects the disease pathogenesis/mechanism defined in Step 1, as they directly assess the effect of LRRK2 on its substrate Akt1, which is central to cell survival and apoptosis, relevant to neurodegeneration in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper includes both wild-type and mutant forms of LRRK2 in the assays, providing variant controls. It also mentions the use of recombinant proteins and intact cells, which are standard techniques in the field."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The variant G2019S in LRRK2 showed significantly weaker kinase activity of Akt1 (Ser473)-phosphorylation than the wild-type LRRK2, suggesting a loss of function mechanism that could contribute to neurodegeneration in Parkinson's disease. The functional evidence is very strong due to the clear disease mechanism, the applicability of the assays, and the direct comparison with wild-type LRRK2."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the causal molecule for autosomal-dominant familial Parkinson’s disease, although its true function, including its physiological substrates, remains unknown. Parkinson’s disease (PD) is the second most common neurodegenerative disorder caused by loss of nigrostriatal dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as neurodegeneration caused by loss of dopaminergic neurons, which is relevant to the functional assay being described for the LRRK2 variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro kinase assay with recombinant proteins and knockdown experiment using intact cells were used to demonstrate that LRRK2 directly phosphorylates Akt1, a central molecule involved in signal transduction for cell survival and prevention of apoptosis.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used, in vitro kinase assays and knockdown experiments, effectively models or reflects the disease pathogenesis/mechanism defined in Step 1, as they directly assess the effect of LRRK2 on its substrate Akt1, which is central to cell survival and apoptosis, relevant to neurodegeneration in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper includes both wild-type and mutant forms of LRRK2 in the assays, providing variant controls. It also mentions the use of recombinant proteins and intact cells, which are standard techniques in the field."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The variant I2020T in LRRK2 showed significantly weaker kinase activity of Akt1 (Ser473)-phosphorylation than the wild-type LRRK2, suggesting a loss of function mechanism that could contribute to neurodegeneration in Parkinson's disease. The functional evidence is very strong due to the clear disease mechanism, the applicability of the assays, and the direct comparison with wild-type LRRK2."
    }
  ]
}